Fennec Pharmaceuticals Inc (FRX.TO) has seen a decline in its stock price this week despite positive sales growth reported earlier this year.
Fennec Pharmaceuticals Inc, listed on the TSX under the ticker FRX.TO, has faced stock price fluctuations recently, closing at C$14.51 after a 3.95% drop today. This decline follows a week where the stock slipped 1.46%. Despite these recent challenges, the company has reported significant growth in product sales earlier this year, raising questions about the market's reaction to its fundamentals.
Advertisement
Fennec Pharmaceuticals Inc
FRX.TO
FRX.TO
Fennec Pharmaceuticals Inc
WealthAwesomeMarket cap
$519.70M
52W high
$17.64
52W low
$7.59
1W change
-1.46%
Beta
1.10
Analyst Price Targets
Based on analyst covering FRX · as of Sep 17, 2026
Wall Street analysts forecast FRX stock price to rise 531.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$93.57
+531.4% Upside
Current Price
C$14.82
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on FRX's historical volatility
30-Day Vol
61.7%
Annualized
90-Day Vol
78.6%
Annualized
Trend (90d)
-5.1%
Annualized drift
90d Mean
C$14.55
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$14.73 | C$11.91 – C$18.22 |
| 60 trading days | C$14.64 | C$10.84 – C$19.78 |
| 90 trading days | C$14.55 | C$10.07 – C$21.04 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider Fennec's recent sales growth and market performance while remaining aware of the stock's volatility. The company's fundamentals indicate a growth trajectory, but the current stock price may not fully reflect this potential.
C$14.51 Closing Price Reflects Recent Volatility
Fennec Pharmaceuticals' stock has fluctuated significantly, with a 52-week range of C$7.59 to C$17.64, indicating potential for both gains and losses.
Bull case
Fennec's recent financial results show promising growth, with net product sales rising 78% year-over-year in Q2 2026. This growth, along with increasing demand for its products, suggests a strong future performance.
Bear case
Despite the positive sales figures, Fennec's stock has faced declines, and its profit margin remains negative at -5.5%. Investors should be cautious about the volatility and the company's current financial health.
Recent Price Action
Fennec Pharmaceuticals Inc's stock has closed at C$14.51, reflecting a 3.95% decline today. Over the past week, the stock has decreased by 1.46%, and its performance over the last month shows a drop of 12.82%. However, year-to-date, the stock has gained 42.36%, indicating a strong start to the year despite recent fluctuations.
Company News and Developments
Advertisement
No major news has been reported this week that could directly impact Fennec's stock price. However, the company previously announced a significant 78% year-over-year increase in net product sales for Q2 2026, amounting to $17.1 million. This growth reflects sustained demand for its PEDMARK® product, which may positively influence investor sentiment in the longer term.
Technical Picture
From a technical perspective, Fennec's stock is currently trading below its 50-day moving average of C$15.72, indicating a bearish short-term trend. The 200-day moving average stands at C$12.36, which is 17.4% below the current price, suggesting a more favorable long-term outlook. The stock has a beta of 1.10, indicating it is slightly more volatile than the market. The recent trading volume of 208 shares is substantially lower than the 20-day average volume of 1,164 shares, indicating reduced trading activity.
Insider Activity
There were no reported insider transactions this week that could provide additional insights into the company's current standing or investor sentiment.
Price Action Summary
Fennec Pharmaceuticals Inc closed at C$14.51, reflecting a 3.95% decrease on the day. Investors are advised to monitor the stock's performance closely, as recent sales growth contrasts with the current market sentiment.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
